Get started
Author

Urja Lathia

Observed names: U Lathia, U. Lathia
ORCID: 0000-0003-2757-7312
Observed ORCID: 0000-0003-2757-7312
OpenAlex ID: A5032987650
Impact of adherence to biological agents on health care resource utilization for patients over the age of 65 years with rheumatoid arthritis
2017 · Urja Lathia, Emmanuel Ewara, et al. · Patient Preference and Adherence · 20
PDF
Persistence to subcutaneous biological agents in Hungarian patients treated for inflammatory arthritis
2019 · Peter Takacs, Urja Lathia, et al. · Patient Preference and Adherence · 6
PDF
Cardiometabolic comorbidity and health outcomes of persons with metabolic dysfunction–associated steatotic liver disease (MASLD) in Ontario, Canada
2026 · Keyur Patel, Diego Moreno Baca, et al. · Canadian Liver Journal · 1
PDF
Health care resource utilization and cost of metabolic dysfunction–associated steatotic liver disease (MASLD) in Ontario, Canada: An observational study
2026 · Keyur Patel, Diego Moreno Baca, et al. · Canadian Liver Journal
EE342 Healthcare Utilization and Cost of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Ontario, Canada: An Observational Study
2025 · Keyur Patel, Diego Moreno Baca, et al. · Value in Health
SAT0611 The Impact of Adherence To Biologic Agents on Health Care Resource Utilization for Patients with Rheumatoid Arthritis
2016 · U. Lathia, F. Nantel, et al. · Annals of the Rheumatic Diseases
Cost Effectiveness of Dose Optimized Ustekinumab Versus Switching to Anti-Tnfs Following Partial Response to Ustekinumab Every Twelve Weeks in Patients with Moderate to Severe Plaque Psoriasis
2016 · Y Poulin, U Lathia, et al. · Value in Health
The Impact of Adherence to Biologic Agents on Health Care Resource Utilization for Patients With Rheumatoid Arthritis
2016 · U. Lathia, F. Nantel, et al. · Value in Health
PDF
Works count: 8
Citation count: 27
H-index: 2
I10-index: 1
Year
Topic
Type